Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

159 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00122317

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Stanford University Medical Center, Division of Hematology Stanford, California, United States
  • Hartford Hospital, Cancer Clinical Research Office Hartford, Connecticut, United States
  • Cleveland Clinic Florida, Department of Clinical Research Weston, Florida, United States
  • Indianapolis University Cancer Center Indianapolis, Indiana, United States
View all 40 locations
View Trial Details

Related conditions